IPHA
Innate Pharma
IPHA
IPHA
13 hedge funds and large institutions have $2.58M invested in Innate Pharma in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
AA
ALPS Advisors
Denver,
Colorado
|
$0 |
| 2 |
Jane Street
New York
|
$0 |
| 3 |
Two Sigma Investments
New York
|
$68K |
| 4 |
Millennium Management
New York
|
$46K |
| 5 |
BlackRock
New York
|
$1.34M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $1.34M | -$19.3K | -7,133 | -1% |
|
2
Optiver Holding
Amsterdam,
Netherlands
| $491K | +$386K | +142,970 | +367% |
|
3
Bank of America
Charlotte,
North Carolina
| $473K | +$121 | +45 | +0% |
|
4
Morgan Stanley
New York
| $126K | +$4.45K | +1,644 | +4% |
|
|
5
Two Sigma Investments
New York
| $68K | -$29K | -10,800 | -30% |
|
|
6
Millennium Management
New York
| $46K | -$22.5K | -8,259 | -33% |
|
7
UBS Group
Zurich,
Switzerland
| $8K | +$8K | +2,956 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $7K | +$7K | +2,600 | New |
|
9
Barclays
London,
United Kingdom
| $6K | -$3.39K | -1,232 | -36% |
|
|
CS
10
Credit Suisse
Zurich,
Switzerland
| $5K | +$5K | +1,981 | New |
|
11
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| $2K | – | – | – |
|
|
SPIA
12
Steward Partners Investment Advisory
New York
| $1K | – | – | – |
|
|
AA
13
ALPS Advisors
Denver,
Colorado
| – | -$282K | -83,966 | Closed |
|
|
14
Jane Street
New York
| – | -$127K | -37,736 | Closed |
|
15
Osaic Holdings
Scottsdale,
Arizona
| – | -$3K | -1,000 | Closed |
|